Predictable delivery under pressure
Fast, reliable brain health clinical trial delivery, backed by specialist expertise, strong participant retention and audit-ready data.
Why sponsors trust NeuroClnx to deliver
In brain health research, trust is earned through reliable performance.
Sponsors return to NeuroClnx time after time, because we consistently deliver where it matters most. Across study activation, strong recruitment, participant retention, data quality, we deliver predictable delivery under pressure.
We’ve been supporting clinical research since 1999 and bring more than 25 years of brain health clinical trial experience to every programme.
Our team of 45 dedicated specialists, including physicians, psychologists, infusion-trained nurses, pharmacists, highly trained raters and patient liaison teams, ensure studies perform as planned.
Conditions we diagnose
24 hours
From green light to first patient visit
78%
Of participants complete the study
Zero
We’ve never had a critical audit finding
Confidence built on performance
Our results speak for themselves:
- The #1 recruiting UK site in a global Phase 3 Alzheimer’s programme, 48% of total recruitment across 12 competing UK sites
- Over 4,500 participants actively engaged with us
- 24 hours from green light to first patient visit
- 98% of participants would recommend us to friends and family
- Capacity for up to 45 participants a day at our clinics
Predictable delivery evidenced time and again.
NeuroClnx conducts clinical trials
in a range of areas including:
Site capabilities
Fast start-up, recruitment performance, participant retention and data quality all shape study success and timelines.
Learn more about the capabilities behind our delivery record.
Brain health expertise
Complex eligibility criteria, specialist assessments, caregiver involvement and long study durations all raise delivery risk.
Learn more about how our experience in complex trial types enables our delivery in all types of brain health studies.
Participant recruitment
Recruitment delay is still the most common cause of timeline slippage. How a site finds, screens and keeps participants is the question behind every feasibility call.
Learn more about how we recruit, and how we stay compliant doing it.
Discuss your next study
Whether you’re assessing sites for an upcoming study, testing recruitment feasibility, or looking for reliable support on a milestone-critical programme, our team is here to help.
Talk to us about study requirements, patient populations, site capacity, timelines and delivery expectations.
Get in touch to learn how we can help your study stay on track.
"*" indicates required fields
Latest news
View allWelcome to NeuroClnx: The Next Chapter in Our Journey
Women in Neuroscience & Clinical Research: Driving Innovation at NeuroClnx
What is Parkinson’s Disease?
My Journey at NeuroClnx and Why I’m Running for Parkinson’s Research
Understanding Alzheimer’s Disease
NeuroClnx appoints new Chief Executive
NeuroClnx and Dementia Action Week 2024: Together Towards Better Diagnosis
How Dementia Affects Women Differently
A Year of Progress: Reflecting on 2023 at NeuroClnx
Scoring Hope and Memories: Tackling Alzheimer’s in World Alzheimer’s Month
